The global subunit vaccine market is anticipated to grow at a significant CAGR of 10.9% during the forecast period (2022-2028). One of the core factors that is fueling the market is the several benefits of subunit vaccines over the others. Despite the success of the traditional vaccine, these conventional approaches are inadequate in their ability to target many other significant pathogens. Several alternative vaccination methods, such as a subunit vaccine, have been developed for overcoming these limitations.
Browse the full report description of “Global Subunit Vaccine Market Size, Share & Trends Analysis Report by Product Type (Protein Antigen, and Polysaccharide Antigen), by Production Type (Denaturing of Proteins, and Genetic Engineering), by Immune Responses Type (Antigen-Presenting Cells (APCs), Cell-Mediated Immunity, Cytokines, Mucosal, and Others), and by Disease (Infectious Disease, Diphtheria, Tetanus and Pertussis (DTP), HPV, Measles, Mumps and Rubella (MMR), and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/subunit-vaccine-market
As compared to the whole-pathogen vaccine approach, a subunit vaccine only includes specific components originating from disease-causing viruses, parasites, orbacteria. These components, else known as antigens, are highlysynthetic peptidesor purified proteins that are considerably safer than whole-pathogen vaccine methods.Rather than injecting a whole pathogen to generate an immune response, subunit vaccines (also called acellular vaccines) hold purified pieces of it, which have been specially selected for their ability to stimulate immune cells. Since these fragments are incapable of causing disease, subunit vaccines are measuredto be very safe.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product Type
o By Production Type
o By Immune Responses Type
o By Disease
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GE Healthcare Life Sciences, GlaxoSmithKline PLC, Merck & Co. Inc., Reber Genetics, Sanofi S.A., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Subunit VaccineMarket Report Segment
By Product Type
• Protein Antigen
• Polysaccharide Antigen
By Production Type
• Denaturing of Proteins
• Genetic Engineering
By Immune Responses Type
• Antigen-Presenting Cells (APCS)
• Cell-Mediated Immunity
• Cytokines (Direct Th1 Or Th2 Immune Responses)
• Mucosal
• Others
By Disease
• Infectious Disease
• Diphtheria, Tetanus and Pertussis (DTP)
• HPV
• Measles, Mumps and Rubella (MMR)
• Others
Global Subunit Vaccine Market Report Segment by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/subunit-vaccine-market